EsoCap is developing a novel smart drug delivery technology enabling targeted and long-lasting local therapy of the esophagus for the first time. Our business model is to demonstrate the clinical feasibility in one indication, (EoE), and to enter into a transaction with a major partner.

Location

Malzgasse 9, 4052 Basel, Switzerland

Facts & figures
  • Type of organization

    Private company

  • Year of foundation

    2017

  • Number of employees in Switzerland

    1-9

Key business